On Friday, Compass Therapeutics Inc (NASDAQ: CMPX) was -5.19% drop from the session before settling in for the closing price of $3.08. A 52-week range for CMPX has been $0.76 – $4.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -6.73%. With a float of $80.27 million, this company’s outstanding shares have now reached $137.59 million.
The firm has a total of 32 workers. Let’s measure their productivity. In terms of profitability, gross margin is 74.8%, operating margin of -1501.0%, and the pretax margin is -1292.88%.
Compass Therapeutics Inc (CMPX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Compass Therapeutics Inc stocks. The insider ownership of Compass Therapeutics Inc is 41.66%, while institutional ownership is 39.07%.
Compass Therapeutics Inc (CMPX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -6.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.99% during the next five years compared to 12.88% growth over the previous five years of trading.
Compass Therapeutics Inc (NASDAQ: CMPX) Trading Performance Indicators
You can see what Compass Therapeutics Inc (CMPX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 31.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 472.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Compass Therapeutics Inc (CMPX)
Analysing the last 5-days average volume posted by the [Compass Therapeutics Inc, CMPX], we can find that recorded value of 1.03 million was lower than the volume posted last year of 2.13 million. As of the previous 9 days, the stock’s Stochastic %D was 11.35%. Additionally, its Average True Range was 0.34.
During the past 100 days, Compass Therapeutics Inc’s (CMPX) raw stochastic average was set at 58.72%, which indicates a significant increase from 5.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.57% in the past 14 days, which was lower than the 105.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.38, while its 200-day Moving Average is $1.66. Now, the first resistance to watch is $3.13. This is followed by the second major resistance level at $3.34. The third major resistance level sits at $3.48. If the price goes on to break the first support level at $2.78, it is likely to go to the next support level at $2.64. Now, if the price goes above the second support level, the third support stands at $2.43.
Compass Therapeutics Inc (NASDAQ: CMPX) Key Stats
There are 137,589K outstanding shares of the company, which has a market capitalization of 401.76 million. As of now, sales total 0 K while income totals -42,490 K. Its latest quarter income was 850 K while its last quarter net income were -13,080 K.
